Pay in 4 interest-free payments of $6.21 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Those with a BMI of 27 or higher and health problems might also get them
In contrast to established GLP-1 receptor agonists such as Semaglutide (marketed as Wegovy and Ozempic) or dual-acting agents like Tirzepatide, Retatrutide is designed as a triple agonist that simultaneously activates GLP-1, GIP, and glucagon receptors
Don't just take our word for it, hear from our satisfied clients who have successfully achieved their weight loss goals with us
Published pricing reflects weekly dose tiers after NP evaluation
US$ 26.14
US$ 27.81
US$ 27.52
US$ 26.52
US$ 23.14
US$ 22.09
US$ 25.70
US$ 22.66
